Jing Pan1, Peng Zhao1, Hao Cai1, Lei Su1, Kristofer Wood2, Fu-Dong Shi1,2, Ying Fu1. 1. Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China. 2. Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Abstract
AIMS: Among patients with neuromyelitis optica spectrum disorder (NMOSD), fatigue is commonly complained about and is one of the most debilitating symptoms. This study aimed to investigate the incidence of fatigue and explore impacting factors attributed to fatigue in NMOSD. METHODS: Thirty-three patients with NMOSD and twenty matched healthy controls were enrolled. A battery of self-reported questionnaires was conducted to assess quality of sleep, daytime sleepiness, fatigue, depression, and level of activity of daily life. The structure of sleep was assessed by polysomnography with blood oxygen saturation monitored by noninvasive pulse oximeter. Brain and spinal cord lesions were evaluated by MRIs. RESULTS: Fatigue was more severe and more prevalent among the patients with NMOSD compared with controls (fatigue score which ranges from 0 to 11 with higher scores indicating more severe fatigue: 6.4 ± 0.6 vs. 3.8 ± 0.4, P = 0.002; incidence, 64% vs. 35%, P = 0.043), and it was negatively associated with daily activity level (r = 0.455, P = 0.008). The patients with fatigue had higher Pittsburgh Sleep Quality Index score, higher Epworth Sleepiness Scale score, lower blood oxygen state, and higher depression score than patients without fatigue; blood oxygen was especially negatively correlated with fatigue (nadir SpO2 , r = -0.558, P = 0.001; mean SpO2 , r = -0.457, P = 0.007); depression was also positively correlated with fatigue (r = 0.599, P < 0.001). CONCLUSION: Patients with NMOSD experienced significant fatigue, which had an obvious impact on their daily activity. Fatigue in these patients was related to hypoxemia, sleep disturbances, and depression.
AIMS: Among patients with neuromyelitis optica spectrum disorder (NMOSD), fatigue is commonly complained about and is one of the most debilitating symptoms. This study aimed to investigate the incidence of fatigue and explore impacting factors attributed to fatigue in NMOSD. METHODS: Thirty-three patients with NMOSD and twenty matched healthy controls were enrolled. A battery of self-reported questionnaires was conducted to assess quality of sleep, daytime sleepiness, fatigue, depression, and level of activity of daily life. The structure of sleep was assessed by polysomnography with blood oxygen saturation monitored by noninvasive pulse oximeter. Brain and spinal cord lesions were evaluated by MRIs. RESULTS:Fatigue was more severe and more prevalent among the patients with NMOSD compared with controls (fatigue score which ranges from 0 to 11 with higher scores indicating more severe fatigue: 6.4 ± 0.6 vs. 3.8 ± 0.4, P = 0.002; incidence, 64% vs. 35%, P = 0.043), and it was negatively associated with daily activity level (r = 0.455, P = 0.008). The patients with fatigue had higher Pittsburgh Sleep Quality Index score, higher Epworth Sleepiness Scale score, lower blood oxygen state, and higher depression score than patients without fatigue; blood oxygen was especially negatively correlated with fatigue (nadir SpO2 , r = -0.558, P = 0.001; mean SpO2 , r = -0.457, P = 0.007); depression was also positively correlated with fatigue (r = 0.599, P < 0.001). CONCLUSION:Patients with NMOSD experienced significant fatigue, which had an obvious impact on their daily activity. Fatigue in these patients was related to hypoxemia, sleep disturbances, and depression.
Authors: N Suzuki; T Takahashi; M Aoki; T Misu; S Konohana; T Okumura; H Takahashi; S Kameya; K Yamaki; T Kumagai; K Fujihara; Y Itoyama Journal: Neurology Date: 2010-05-11 Impact factor: 9.910
Authors: P J Waters; A McKeon; M I Leite; S Rajasekharan; V A Lennon; A Villalobos; J Palace; J N Mandrekar; A Vincent; A Bar-Or; S J Pittock Journal: Neurology Date: 2012-02-01 Impact factor: 9.910
Authors: Yong Guo; Vanda A Lennon; Bogdan F Gh Popescu; Carrie Katherine Grouse; Jordan Topel; Margherita Milone; Hans Lassmann; Joseph E Parisi; Sean J Pittock; Dusan Stefoski; Roumen Balabanov; Claudia F Lucchinetti Journal: JAMA Neurol Date: 2014-08 Impact factor: 18.302
Authors: Carlos A Sánchez-Catasús; José Cabrera-Gomez; William Almaguer Melián; José Luis Giroud Benítez; Rafael Rodríguez Rojas; Jorge Bosch Bayard; Lídice Galán; Reinaldo Galvizu Sánchez; Nancy Pavón Fuentes; Pedro Valdes-Sosa Journal: PLoS One Date: 2013-06-18 Impact factor: 3.240
Authors: Adriana Medina; Stanley J Watson; William Bunney; Richard M Myers; Alan Schatzberg; Jack Barchas; Huda Akil; Robert C Thompson Journal: J Psychiatr Res Date: 2015-10-23 Impact factor: 4.791